nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achieving human brain exposure with the oral ataxia-telangiectasia mutated kinase inhibitor AZD1390, a substrate of aldehyde oxidase
|
Colclough, Nicola |
|
|
53 |
8 |
p. |
artikel |
2 |
Age-dependent pharmacokinetics of nifedipine in spontaneous hypertensive rats are associated with changes in gut microbiota and hepatic CYP3A1 expression
|
Xiong, Yalan |
|
|
53 |
8 |
p. |
artikel |
3 |
CYP1A2 expression and activity in a large panel of human nonneoplastic surgical liver samples: Influence of genetics, lifestyle, and other factors
|
Kuhn, Urs Dieter |
|
|
53 |
8 |
p. |
artikel |
4 |
Differential protein expressions of hepatic drug-metabolizing enzymes between White and Black Americans and the associated genetic polymorphisms
|
Jung, Sun Min |
|
|
53 |
8 |
p. |
artikel |
5 |
Early-stage prediction of human intestinal metabolism from in vitro liver microsomal clearance
|
Arey, Ryan |
|
|
53 |
8 |
p. |
artikel |
6 |
Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease
|
Zhu, Xia |
|
|
53 |
8 |
p. |
artikel |
7 |
Evaluation of various experimental conditions and mechanistic static versus dynamic models to predict time-dependent CYP3A4/5 inhibition potential of drugs
|
Justine, Badée |
|
|
53 |
8 |
p. |
artikel |
8 |
Human metabolism of zamicastat, an oral dopamine β-hydroxylase inhibitor
|
Loureiro, Ana Isabel |
|
|
53 |
8 |
p. |
artikel |
9 |
Hydroxylation near the epoxyketone of carfilzomib confers protection from microsomal epoxide hydrolase-mediated metabolism
|
Lee, Seongsoo |
|
|
53 |
8 |
p. |
artikel |
10 |
Impact of cytosolic aldehyde oxidase contamination in liver microsomes on intrinsic clearance estimations
|
Tang, Lloyd Wei Tat |
|
|
53 |
8 |
p. |
artikel |
11 |
Kinetic and mechanistic investigation toward the characterization of tucatinib inhibition of CYP3A4
|
Sun, Hao |
|
|
53 |
8 |
p. |
artikel |
12 |
Nonclinical absorption, distribution, metabolism, excretion and biomarkers properties of a modified N-acetylgalactosamine–conjugated small-interfering RNA for hypercholesteremia
|
Dou, Dehu |
|
|
53 |
8 |
p. |
artikel |
13 |
Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors
|
Schneider, Mathew |
|
|
53 |
8 |
p. |
artikel |
14 |
Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib
|
Heikkinen, Aki T. |
|
|
53 |
8 |
p. |
artikel |
15 |
Regulation of expression and activity of hepatic transporters by pregnancy-related hormones in HepaRG cells
|
Sharma, Sejal |
|
|
53 |
8 |
p. |
artikel |
16 |
The application of mechanistic absorption, distribution, metabolism and excretion studies and physiologically-based pharmacokinetic modeling in the discovery of the next-generation oral selective estrogen receptor degrader camizestrant to achieve an acceptable human pharmacokinetic profile
|
Gangl, Eric T. |
|
|
53 |
8 |
p. |
artikel |